Suppliers / Jetpharma

Jetpharma

Switzerland 60 employees 2 duplicate records merged Updated 9 July 2026

Jetpharma is an API and finished-dose manufacturer based in Switzerland. It appears in 21 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 23 June 2023 as NAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
21
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 23 June 2023 NAI US FDA
  • 7 February 2020 VAI US FDA
  • 1 December 2017 VAI US FDA
  • 29 January 2016 VAI US FDA
  • 8 May 2013 NAI US FDA
  • 16 February 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Balerna, Switzerland Not on file
Switzerland, Switzerland 3002807359

What they file, and where

Molecule Regulators Docs
Roflumilast SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Anastrozole finished dose Bicalutamide finished dose Gemcitabine finished dose Glimepiride finished dose Meloxicam finished dose Mycophenolate Mofetil finished dose Pioglitazone finished dose Pravastatin finished dose Risperidone finished dose Roflumilast API Sertraline finished dose Sumatriptan finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 21 None
US FDA None 1
EMA None 1

Questions about Jetpharma

Does Jetpharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Jetpharma. It does have 21 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Jetpharma FDA-registered?
One site operated by Jetpharma carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Jetpharma's last inspection go?
The most recent inspection on record closed on 23 June 2023 as NAI (No Action Indicated: nothing objectionable was found). 6 inspections are on file.
Where does Jetpharma manufacture?
2 registered sites are on record, in Switzerland (Balerna and Switzerland). Every site is listed on this page with the register it came from.
What does Jetpharma make?
1 molecule is on record against Jetpharma, including Roflumilast. Each links through to that molecule's full manufacturer list.
Which regulators recognise Jetpharma's GMP?
Current GMP certificates are on record from US FDA and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jetpharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 23 June 2023.

Comparable suppliers

MSN Laboratories shares 1 molecule Apitoria Pharma shares 1 molecule Hetero shares 1 molecule Alivus Life Sciences shares 1 molecule Matrix Pharmacorp shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates